Newest Option for Managing Post-Prandial Glucose – Certificate of Completion

The objectives of this presentation include:

1. Evaluate the scope of postprandial hyperglycemia in people on bolus insulin;
2. Explain the rationale for the newest option in rapid-acting insulins;
3. Describe the purpose and design of the ONSET trials 1, 2, and 3; and
4. Describe patient profiles being assessed in the Patient Practice Assessment (PPA).